With new chapters focused on today’s changing healthcare issues, a recently released fifth edition of “Pharmacotherapeutics for Advanced Practice Nurse Prescribers” boasts strong ties to CU Nursing.
Faculty members Nicole Brodrick, DNP, Lisa Diamond, DNP, Krista Estes, DNP, and Jennifer Fisher, DNP, contributed to the book’s revision, along with Marcia Gilbert, DNP, formerly of CU Nursing.
“With today’s evolving healthcare issues and the continued advancements in pharmaceutical treatments, the update provides critical guidance for tomorrow’s advanced nurse practitioners,” said Assistant Professor Lisa Diamond, who co-edited a chapter on urinary tract infections with Estes.
“For example, our understanding of best treatments complicated by antibiotic resistance have changed the way we treat UTIs,” Diamond said.
From ADHD to transgender care, today’s issues spur new chapters
New chapters in this edition target addiction, transgender patient care, Attention-Deficit Hyperactivity Disorder and drugs affecting bones and joints.
“Pharmacologic considerations for the transgender population have been added to this new edition as well as to our curriculum,” Diamond said.
It is important, for example, that advanced practice nurses understand the effects hormone therapy can have on other medications, she said.
Treatment of drug and alcohol addiction also raises complicated pharmacologic issues and remains timely with the rise in alcohol and opioid abuse in this country.
“For instance, many drugs are cleared from the body through the liver and, with substance abuse, patients can be at an increased risk of liver failure when undergoing prescription drug treatment,” Diamond said.
The textbook includes case studies for each body system and Davis Edge, an interactive, online quizzing program provided free with the book.
Half of the book’s 14 contributors have ties to the CU Anschutz Medical Campus. Former CU Nursing faculty member Marylou Robinson co-authored the book, published by F.A. Davis.
April 15, 2024